Nymbl Systems receives investment
By HME News Staff
Updated 9:09 AM CST, Mon December 23, 2024
COLUMBUS, Ohio – Nymbl Systems, a provider of cloud-based practice management software for orthotics and prosthetics, complex rehab technology and home medical equipment providers, has received an equity investment from Frontier Growth.
The amount of the deal was not disclosed, but Charlotte-based Frontier Growth typically makes initial equity investments of $5 million to $30 million in mission critical vertical SaaS companies with $3 million to $20 million of annual recurring revenue and +25% annual growth.
Nymbl says it plans to use the funds to accelerate its growth, drive continued product innovation and enhance its ability to support health care providers nationwide.
"This partnership with Frontier Growth is a major milestone for Nymbl Systems," said Josh Lau, CEO of Nymbl Systems. "Their deep expertise in scaling vertical SaaS businesses, combined with their 'people-first culture' aligns perfectly with our customer-centric approach, making them the ideal partner to help us achieve our growth objectives. We're excited to partner with Frontier to expand our reach, develop even more innovative solutions for our customers, and strengthen our mission to help providers deliver exceptional care while optimizing their operations."
In conjunction with the investment, Dave Pandullo will join the company’s board of directors, alongside existing investors Ben Trumbull of Tamarind Hill, Josh Lau and Chad Feinberg of Nymbl and Mike Morgan (independent director) formerly of Updox.
Nymbl says its solutions, which streamline workflows, enhance efficiency and accelerate revenue by automating processes such as clinical notes and patient intake, are used by hundreds of O&P, CRT and HME businesses.
"Nymbl Systems is transforming how healthcare providers manage critical workflows," said Dave Pandullo, partner at Frontier Growth. "We were extremely impressed by Nymbl's track record of product innovation and exceptional customer trust they've earned, as evidenced by their strong market traction with hundreds of providers across the U.S. We're excited to partner with the Nymbl team to support their vision of driving continued innovation and improving outcomes for the O&P, CRT and HME markets. We believe there's a compelling opportunity for Nymbl to continue winning its market, further amplifying value to its customers, and ultimately transform these verticals.”
Comments